YAP1 and neoplasm: Clinicopathological and biological analyses suggest that the expression of YAP1 target genes is correlated with tumor progression in non-small cell lung cancer [5,16,17], triple-negative breast cancer [18,19,20], and colorectal carcinoma [21,22].